This description is a summary of our understanding of the job description. Click on 'Apply' button to find out more. Role Description The Director of Pricing, Contracting and Government Programs will report to the Executive Director of Market Access and Value. This leader will be primarily responsible for government price reporting validation, contract execution and pricing recommendations. Proactively assess and develop contracting strategies and tactics to effectively overcome barriers to access for Replimune products. This position can be based either in our Woburn office or be a remote role. Responsibilities - Responsible for the approach, design and tactics to maximize uptake in preferred formulary positions and contract profitability. - Optimize any rebate programs through account specific pull-through and communication tools and resources. - Collaborate with the Account Teams to identify opportunities to expand account collaborations beyond a transactionable focus. - Develop strategy and support for additional account interactions beyond contracting to create collaborations and key account partnerships. - Create programs to maximize forecasting and revenue recognition with external vendors. - Coordinate revenue recognition factors with internal and external partners. - Validate chargeback reporting using distribution data supplied by external vendors. - Monitor contract performance using developed key performance metrics. - Be responsible for managing the Return Goods policy with 3PL. - Execute required government reporting requirements either internally or with contracted vendors. - Ensure compliance with all necessary pricing policies at the national or state level. - Proactively collaborate with Account Teams to identify competitive and account specific opportunities and threats to ensure optimal access to Replimune products. - Willing to undertake various responsibilities outside of your area of expertise as opportunity presents. Qualifications - Bachelor’s degree required, preferably in the Finance field. - MBA strongly preferred. - CPA a plus. - 10+ years of biotech/pharma experience with 5 years fully accountable for managing pricing and contracting deliverables. - Experience in buy and bill model with commercial and government-based payers. - Oncology experience strongly preferred. - Strong leadership and collaboration skills and the ability to drive consensus. - Proficient in Microsoft Word, PowerPoint and Excel. - Deep understanding of performance and operational indicators of success. - Demonstrated experience forecasting and managing vendor budgets. - Strong background in pharma data platforms. - Demonstrated negotiation skills and ability to make sound business arguments to influence internal and external decision makers. - Extensive communication and collaboration skills and the ability to drive consensus. - Ability to thrive in a fast-paced start-up environment with high expectations and accountability for the quality and timing of deliverables. - Willing to undertake various responsibilities outside of your area of expertise. - Experience in influence management across internal stakeholders and external partners. Benefits - Medical, dental, and vision insurance. - 401k match. - Flexible time off. - A number of paid holidays including year-end shutdown. Company Description Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options.